Vessella RL - Search Results

1

KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer.

Chen C, Bhalala HV, Vessella RL, Dong JT. Chen C, et al. Among authors: vessella rl. Prostate. 2003 May 1;55(2):81-8. doi: 10.1002/pros.10205. Prostate. 2003. PMID: 12661032

2

Defining the region(s) of deletion at 6q16-q22 in human prostate cancer.

Hyytinen ER, Saadut R, Chen C, Paull L, Koivisto PA, Vessella RL, Frierson HF Jr, Dong JT. Hyytinen ER, et al. Among authors: vessella rl. Genes Chromosomes Cancer. 2002 Jul;34(3):306-12. doi: 10.1002/gcc.10065. Genes Chromosomes Cancer. 2002. PMID: 12007191

3

Deletion, mutation, and loss of expression of KLF6 in human prostate cancer.

Chen C, Hyytinen ER, Sun X, Helin HJ, Koivisto PA, Frierson HF Jr, Vessella RL, Dong JT. Chen C, et al. Among authors: vessella rl. Am J Pathol. 2003 Apr;162(4):1349-54. doi: 10.1016/S0002-9440(10)63930-2. Am J Pathol. 2003. PMID: 12651626 Free PMC article.

4

Microsatellite instability and mismatch repair target gene mutations in cell lines and xenografts of prostate cancer.

Sun X, Chen C, Vessella RL, Dong JT. Sun X, et al. Among authors: vessella rl. Prostate. 2006 May 1;66(6):660-6. doi: 10.1002/pros.20390. Prostate. 2006. PMID: 16388502

5

FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer.

Dong XY, Chen C, Sun X, Guo P, Vessella RL, Wang RX, Chung LW, Zhou W, Dong JT. Dong XY, et al. Among authors: vessella rl. Cancer Res. 2006 Jul 15;66(14):6998-7006. doi: 10.1158/0008-5472.CAN-06-0411. Cancer Res. 2006. PMID: 16849544

6

Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer.

Sun X, Frierson HF, Chen C, Li C, Ran Q, Otto KB, Cantarel BL, Vessella RL, Gao AC, Petros J, Miura Y, Simons JW, Dong JT. Sun X, et al. Among authors: vessella rl. Nat Genet. 2005 Apr;37(4):407-12. doi: 10.1038/ng1528. Epub 2005 Mar 6. Nat Genet. 2005. PMID: 15750593

7

SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer.

Dong XY, Rodriguez C, Guo P, Sun X, Talbot JT, Zhou W, Petros J, Li Q, Vessella RL, Kibel AS, Stevens VL, Calle EE, Dong JT. Dong XY, et al. Among authors: vessella rl. Hum Mol Genet. 2008 Apr 1;17(7):1031-42. doi: 10.1093/hmg/ddm375. Epub 2008 Jan 17. Hum Mol Genet. 2008. PMID: 18202102 Free PMC article.

8

Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer.

Chen C, Sun X, Guo P, Dong XY, Sethi P, Zhou W, Zhou Z, Petros J, Frierson HF Jr, Vessella RL, Atfi A, Dong JT. Chen C, et al. Among authors: vessella rl. Oncogene. 2007 Apr 5;26(16):2386-94. doi: 10.1038/sj.onc.1210021. Epub 2006 Oct 2. Oncogene. 2007. PMID: 17016436

9

Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer.

Waltering KK, Wallén MJ, Tammela TL, Vessella RL, Visakorpi T. Waltering KK, et al. Among authors: vessella rl. Prostate. 2006 Nov 1;66(15):1585-91. doi: 10.1002/pros.20387. Prostate. 2006. PMID: 16927275

10

Screening of genetic and expression alterations of SRC1 gene in prostate cancer.

Mäki HE, Waltering KK, Wallén MJ, Martikainen PM, Tammela TL, van Weerden WM, Vessella RL, Visakorpi T. Mäki HE, et al. Among authors: vessella rl. Prostate. 2006 Sep 15;66(13):1391-8. doi: 10.1002/pros.20427. Prostate. 2006. PMID: 16894533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters